Gain expert insight on the latest evidence on TKI therapy and combination approaches for improving outcomes in chronic-phase CML by watching this on-demand Webcast.
Listen to leukemia experts Prof. Dr. med Tim Henrik Brümmendorf; Jorge Cortes, MD; and Carlo Gambacorti-Passerini, MD, answer audience questions from live CCO Webinars on optimizing TKI treatments for patients with chronic-phase chronic myeloid leukemia (CML).
Downloadable ExpressPoints summary slides with key points related to the optimal treatment of chronic phase CML with TKIs.
Downloadable slides with expert analysis of first-line treatment of CP CML with TKIs.
Downloadable slides with expert analysis of CML management after TKI inhibitor intolerance.
Downloadable slides with expert analysis of second-line treatment of CP CML with TKIs after disease progression.
How are you managing your patients with CML after achieving a complete molecular remission on first-line TKI therapy? In this commentary, Prof. Brümmendorf shares his thoughts on treatment-free remission in patients with CML.